Evidence map›Paper›PMID 19909352›Full record

ReviewImmunological reviews2009

Organization of proximal signal initiation at the TCR:CD3 complex.

Clifford S Guy, Dario A A Vignali

Open access · greenAbstract readReview
In one paragraph

Review in Immunological reviews, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 123 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. The transcription factor Zfp281 sustains CD4Cellular & molecular immunology · 2020
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Clifford S GuyDepartment of Immunology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
Dario A A Vignali
St. Jude Children's Research Hospital · US

Funding

Viral Vector Technology (VVTSR)P30CA021765 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI CHARLES ROBERTS · 1985 to 2026
$166.9M
Molecular Control of TCR Signaling and FunctionR01AI052199 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI VIGNALI, DARIO AA · 2003 to 2015
$3.8M
Molecular Control of TCR Signaling and FunctionR56AI052199 · NIAID · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI VIGNALI, DARIO AA · 2010 to 2010
$435k
Molecular Control of TCR Signaling and FunctionR21AI052199 · NIAID · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI VIGNALI, DARIO AA · 2002 to 2002
$375k
NCI NIH HHS CA21765NCI NIH HHS P30 CA021765NIAID NIH HHS AI52199NIAID NIH HHS R01 AI052199NIAID NIH HHS R21 AI052199NIAID NIH HHS R56 AI052199
6 · The paper itself

Abstract

The series of events leading to T-cell activation following antigen recognition has been extensively investigated. Although the exact mechanisms of ligand binding and transmission of this extracellular interaction into a productive intracellular signaling sequence remains incomplete, it has been known for many years that the immunoreceptor tyrosine activation motifs (ITAMs) of the T-cell receptor (TCR):CD3 complex are required for initiation of this signaling cascade because of the recruitment and activation of multiple protein tyrosine kinases, signaling intermediates, and adapter molecules. It however remains unclear why the TCR:CD3 complex requires 10 ITAMs, while many other ITAM-containing immune receptors, such as Fc receptors (FcRs) and the B cell receptor (BCR), contain far fewer ITAMs. We have recently demonstrated that various parameters of T cell development and activation are influenced by the number, as well as location and type, of ITAMs within the TCR:CD3 complex and hence propose that the TCR is capable of 'scalable signaling' that facilitates the initiation and orchestration of diverse T-cell functions. While many of the underlying mechanisms remain hypothetical, this review intends to amalgamate what we have learned from conventional biochemical analyses regarding initiation and diversification of T-cell signaling, with more recent evidence from molecular and fluorescent microscopic analyses, to propose a broader purpose for the TCR:CD3 ITAMs. Rather than simply signal initiation, individual ITAMs may also be responsible for the differential recruitment of signaling and regulatory molecules which ultimately affects T-cell development, activation and differentiation.

Indexed as

Lymphocyte ActivationSignal TransductionAnimalsCell DifferentiationHumansImmunological SynapsesProtein Interaction Domains and MotifsProtein TransportReceptor-CD3 Complex, Antigen, T-CellReceptor Cross-TalkReceptors, CytokineT-LymphocytesReceptor-CD3 Complex, Antigen, T-CellReceptors, Cytokine

Identifiers

PMID19909352
PMCPMC2845712
OpenAlexW1987295549

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.